A 54-year-old female patient with a history of hypertension and hyperlipidemia presents with chest pain and is found to have an ST-segment elevation on her ECG, consistent with an acute myocardial infarction (AMI). Her blood pressure is 145/90 mmHg, heart rate is 120 bpm, and oxygen saturation is 90% despite supplemental oxygen. Which intervention should the nurse prioritize to stabilize the patient’s condition?

C) Prepare for percutaneous coronary intervention (PCI) to restore coronary blood flow.

A) Administer clopidogrel to prevent further platelet aggregation.

B) Initiate high-flow oxygen therapy to improve oxygen saturation.

C) Prepare for percutaneous coronary intervention (PCI) to restore coronary blood flow.

D) Monitor for arrhythmias and administer a proton pump inhibitor for suspected GERD.

A 54-year-old female with a history of hypertension and hyperlipidemia is presenting with chest pain and has been diagnosed with an acute myocardial infarction (AMI) with ST-segment elevation in the anterior leads. Her blood pressure is 145/90 mmHg, heart rate is 120 bpm, and oxygen saturation is 90% despite supplemental oxygen. Which of the following nursing interventions should be prioritized to address her condition?

B) Prepare the patient for immediate percutaneous coronary intervention (PCI).

A) Administer nitroglycerin sublingually to decrease myocardial oxygen demand.

B) Prepare the patient for immediate percutaneous coronary intervention (PCI).

C) Initiate intravenous fluid therapy to increase blood pressure.

D) Administer proton pump inhibitors to manage potential GERD symptoms.

A patient with a recent myocardial infarction is showing signs of acute pulmonary edema, including increased respiratory distress and bilateral pulmonary congestion. After initiating diuretic therapy and positioning the patient upright, what is the next nursing priority to monitor for potential complications?

A) Monitor blood pressure closely for signs of hypotension.

B) Assess the patient's neurological status for changes in alertness.

C) Check for signs of gastrointestinal bleeding due to medication side effects.

D) Evaluate the skin for signs of pressure ulcers due to prolonged immobility.

A patient with a history of hypertension and recent myocardial infarction presents with persistent chest pain, increased respiratory distress, and decreased oxygen saturation after initiation of antiplatelet therapy and high-flow oxygen. Based on the current clinical scenario, what is the priority nursing action?

C) Administer intravenous furosemide to reduce pulmonary congestion.

A) Administer a second dose of antiplatelet medication to improve coronary perfusion.

B) Increase the flow rate of oxygen therapy to improve oxygen saturation.

C) Administer intravenous furosemide to reduce pulmonary congestion.

D) Prepare the patient for immediate intubation due to respiratory failure.

A patient with heart failure and recent myocardial infarction is receiving furosemide therapy. The nurse notes a decrease in the patient's serum potassium level to 3.0 mEq/L. Considering the patient's current condition and treatment, what is the nurse's priority intervention?

B) Implement continuous cardiac monitoring and notify the healthcare provider.

A) Increase the dose of furosemide to manage fluid overload.

B) Implement continuous cardiac monitoring and notify the healthcare provider.

C) Encourage the patient to increase oral fluid intake to prevent dehydration.

D) Discontinue furosemide and switch to a potassium-sparing diuretic.

A patient with a history of myocardial infarction is experiencing hypokalemia after the administration of furosemide. Which nursing intervention should the nurse prioritize to prevent potential complications?

B) Initiate telemetry monitoring to detect any cardiac arrhythmias.

A) Increase the patient's fluid intake to promote potassium reabsorption.

B) Initiate telemetry monitoring to detect any cardiac arrhythmias.

C) Administer a calcium supplement to stabilize cardiac membranes.

D) Encourage early ambulation to improve circulation.

A patient with a history of myocardial infarction is exhibiting signs of increased fatigue, confusion, hypotension, and tachycardia. The nurse notes jugular venous distention and cool, clammy skin. What is the most appropriate initial intervention to address the patient's hemodynamic instability?

B) Administer a fluid bolus to improve cardiac output

A) Increase diuretic dosage to reduce preload

B) Administer a fluid bolus to improve cardiac output

C) Start vasodilator therapy to decrease afterload

D) Initiate a beta-blocker to control heart rate

A patient with a recent myocardial infarction is exhibiting signs of hemodynamic instability, including hypotension, tachycardia, jugular venous distention, and cool, clammy skin. Despite initial stabilization efforts, she continues to show increased fatigue and confusion. The healthcare team is considering reducing diuretic dosage and administering a fluid bolus. Which nursing intervention is most critical at this stage to prevent further deterioration of the patient's condition?

B) Initiate continuous ECG monitoring to detect potential arrhythmias.

A) Monitor the patient's urine output hourly to assess renal function.

B) Initiate continuous ECG monitoring to detect potential arrhythmias.

C) Prepare the patient for emergency dialysis to manage fluid overload.

D) Encourage deep breathing exercises to improve oxygenation.

A patient with reduced ejection fraction and signs of heart failure is receiving dobutamine therapy to improve cardiac output. Which nursing intervention is a priority to minimize the risk of complications associated with this inotropic treatment?

A) Administer supplemental oxygen to maintain SpO2 above 95%

C) Encourage increased oral fluid intake to prevent dehydration

D) Position the patient in a high Fowler's position to improve breathing

A patient with heart failure and a reduced ejection fraction of 35% is receiving inotropic support with dobutamine. Which nursing action is most critical in monitoring for potential complications associated with this therapy?

A) Monitor the patient's heart rate for tachycardia.

B) Assess for signs of fluid overload, such as peripheral edema.

C) Evaluate the patient's pain level using a standardized pain scale.

D) Monitor the patient's respiratory rate for signs of respiratory distress.

Chest pain - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial ischemia - Occurs when coronary arteries are narrowed or blocked, reducing blood flow and oxygen supply to the heart muscle, leading to chest pain, commonly known as angina.

• Secondary mechanism: Gastroesophageal reflux disease (GERD) - Stomach acid flows back into the esophagus, irritating its lining and causing burning chest pain, often mistaken for cardiac-related pain due to proximity.

• Key complication: Myocardial infarction - Prolonged ischemia can cause irreversible heart muscle damage, presenting as severe chest pain and requiring immediate intervention to restore blood flow and minimize cardiac tissue loss.

Patient Profile

Demographics:

54-year-old female, office manager

History:

• Key past medical history: Hypertension, hyperlipidemia

• Current medications: Lisinopril 20 mg daily, Atorvastatin 40 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Intermittent chest pain radiating to the left arm, shortness of breath, nausea, lightheadedness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 37.5°C, oxygen saturation 92% on room air

Section 1

As the healthcare team continues to assess the 54-year-old female patient presenting with chest pain, her condition shows signs of deterioration, necessitating a deeper investigation into potential complications. During the initial assessment, the patient's electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads, raising suspicion of an acute myocardial infarction (AMI). Given her history of hypertension and hyperlipidemia, these findings are significant, pointing towards a potential blockage in the coronary arteries. Blood tests further confirm this diagnosis with elevated cardiac biomarkers, including troponin I, indicating myocardial injury. This data compels the clinical team to expedite treatment to restore coronary blood flow and minimize myocardial damage.

The patient's hemodynamic status also reflects this acute change. Her blood pressure has dropped to 145/90 mmHg, and her heart rate has increased to 120 bpm, suggesting compensatory mechanisms in response to decreased cardiac output. Oxygen saturation remains at 90% despite supplemental oxygen, indicating impaired gas exchange. These changes prompt immediate intervention, including antiplatelet therapy with clopidogrel, high-flow oxygen, and preparation for potential percutaneous coronary intervention (PCI) to alleviate the obstruction in the coronary arteries. The clinical reasoning here involves balancing the need for rapid intervention against the risk of further complications, such as arrhythmias or heart failure.

As the team prepares for further interventions, they must also consider the secondary mechanism of GERD exacerbating her symptoms. The overlap of symptoms between ischemic heart disease and GERD necessitates a collaborative approach to manage her chest pain comprehensively. Proton pump inhibitors may be introduced to decrease gastric acidity, while continuous cardiac monitoring is essential to detect any new arrhythmias. This scenario underscores the importance of a holistic approach to patient care, integrating clinical reasoning to address both immediate and underlying health issues effectively.

Section 2

As the healthcare team continues to monitor the patient closely, they observe a change in her status that prompts further investigation. Approximately one hour after the initiation of antiplatelet therapy and high-flow oxygen, the patient's chest pain persists, and she begins to exhibit signs of increasing respiratory distress. Her respiratory rate has climbed to 28 breaths per minute, and she is using accessory muscles to breathe. Her oxygen saturation has further declined to 85%, raising concerns about pulmonary complications potentially related to heart failure exacerbation.

Concurrent with the respiratory changes, the patient's cardiovascular status shows subtle yet concerning alterations. Her blood pressure has decreased to 135/85 mmHg, and her heart rate remains elevated at 125 bpm, suggesting that compensatory mechanisms are being overwhelmed. Given her history of hypertension and the recent myocardial injury, the team suspects the development of acute pulmonary edema as a complication of left ventricular dysfunction. An urgent chest X-ray is ordered, revealing bilateral pulmonary congestion consistent with fluid overload.

In response to these findings, the clinical team initiates diuretic therapy with intravenous furosemide to alleviate the pulmonary congestion and improve respiratory function. Additionally, the patient is positioned upright to enhance ventilation and reduce the work of breathing. While these steps are taken, the team remains vigilant for any signs of arrhythmia or further hemodynamic instability, as these could complicate her recovery. Continuous monitoring and reassessment are crucial, as the team must balance aggressive management of heart failure symptoms with ongoing efforts to restore coronary perfusion and address her myocardial infarction effectively.

Section 3

As the team closely monitors the patient following the initiation of diuretic therapy, they begin to observe a gradual improvement in her respiratory status. Her respiratory rate decreases to 22 breaths per minute, and she appears less distressed, with a slight reduction in the use of accessory muscles for breathing. Her oxygen saturation has improved modestly to 90%, offering some reassurance that the pulmonary congestion is beginning to resolve with the diuretic intervention. However, the team remains cautious, recognizing that her condition is still precarious, with potential for further complications.

Despite the initial positive response, a new complication emerges as the patient's electrolyte levels are assessed following the administration of furosemide. Her serum potassium level has dropped to 3.0 mEq/L, indicating hypokalemia, which poses a risk for cardiac arrhythmias given her existing myocardial injury. The team quickly initiates potassium replacement therapy to correct the imbalance and prevent any further deterioration in her cardiac function. Additionally, they adjust her telemetry monitoring to detect any early signs of arrhythmias.

Concurrently, a repeat ECG is performed to assess for dynamic changes related to her myocardial infarction. The ECG reveals ST-segment elevation in the anterior leads, confirming the ongoing ischemic insult to the myocardium. This finding prompts the team to reevaluate the effectiveness of her current antiplatelet regimen and consider the need for additional interventions, such as possible revascularization strategies. The team engages in a multidisciplinary discussion, weighing the risks and benefits of more aggressive measures to stabilize her cardiac status while continuing to manage her heart failure symptoms. This coordinated approach is essential as they strive to optimize her recovery and prevent further complications.

Section 4

As the medical team remains vigilant in monitoring the patient's condition, they notice a change in her status that prompts immediate attention. Despite the initial stabilization of her respiratory function, the patient begins to exhibit signs of increased fatigue and confusion, raising concerns about her neurological status. Her blood pressure has dropped to 92/58 mmHg, and her heart rate, previously stable, has climbed to 112 beats per minute. These changes in vital signs suggest a possible hemodynamic instability, warranting further investigation.

A rapid assessment reveals jugular venous distention and cool, clammy skin, indicative of worsening cardiac output and potential progression to cardiogenic shock. The team quickly reassesses her fluid status and considers the impact of the diuretic therapy alongside her myocardial infarction and hypokalemia. They decide to reduce the diuretic dosage and administer a cautious fluid bolus to improve her circulatory status while closely monitoring her response. Additionally, they contemplate initiating inotropic support to enhance myocardial contractility and improve perfusion.

In parallel, the patient's laboratory results return, showing a slight increase in troponin levels, reinforcing the diagnosis of ongoing myocardial injury. The team deliberates over the potential need for urgent coronary angiography to identify and address any critical stenosis contributing to her ischemia. They also reassess her electrolyte management plan, ensuring the potassium replacement is effective while keeping a close eye on her renal function. This nuanced clinical reasoning and prompt intervention aim to stabilize the patient's condition, highlighting the complexity of balancing acute cardiac and renal considerations in her care.

Section 5

In the next phase of the patient's journey, the team closely monitors her response to the administered fluid bolus and the adjustment in diuretic therapy. Initially, there is a slight improvement in her mental status, with a reduction in confusion, suggesting a positive response to the intervention. Her blood pressure rises modestly to 98/62 mmHg, and her heart rate decreases to 105 beats per minute, indicating some stabilization of her hemodynamic status. However, the jugular venous distention persists, and her skin remains cool and clammy, underscoring the need for ongoing vigilance and further intervention.

Simultaneously, the team receives new diagnostic results from the echocardiogram conducted earlier. The findings reveal a reduced ejection fraction of 35%, confirming significant left ventricular dysfunction contributing to her low cardiac output. This new data prompts the team to initiate inotropic support with dobutamine, aiming to enhance myocardial contractility and improve overall perfusion. This decision is made carefully, considering the potential risks and benefits, and the team plans to titrate the dose based on the patient's clinical response and serial monitoring of her hemodynamic parameters.

As the team implements these changes, they also prepare for potential complications. The risk of arrhythmias is a concern with inotropic therapy, necessitating continuous cardiac monitoring. The team remains vigilant in assessing the patient's electrolyte levels, particularly potassium and magnesium, to mitigate arrhythmia risks. Concurrently, they prioritize a collaborative discussion with the cardiology team to expedite plans for coronary angiography, anticipating the potential need for revascularization if critical lesions are identified. Through these coordinated efforts, the team endeavors to stabilize the patient's condition while preparing for the next steps in her care.